| 包装: | 10mg |
| 规格: | 98% |
| 市场价: | 3861元 |
| 分子量: | 542.14 |
Background:
Potent NMDA receptor antagonist (IC50 = 8 nM). Exhibits >100-fold selectivity for hGluN2A (formally hNR2A) containing receptors over hGluN2B (hNR2B). Anticonvulsant in vivo. Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions.
Auberson et al (2002) 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg.Med.Chem.Lett. 12 1099 PMID:11909726
m.cnreagent.com